SUMOylation occurs in acute kidney injury and plays a cytoprotective role

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

SUMOylation is a form of post-translational modification where small ubiquitin-like modifiers (SUMO) are covalently attached to target proteins to regulate their properties. SUMOylation has been demonstrated during cell stress and implicated in cellular stress response. However, it is largely unclear if SUMOylation contributes to the pathogenesis of kidney diseases, such as acute kidney injury (AKI). Here we have demonstrated a dynamic change of protein SUMOylation in ischemic and cisplatin nephrotoxic AKI in mice. In rat kidney proximal tubular cells (RPTC), cisplatin-induced SUMOylation was diminished by two antioxidants (N-acetylcysteine and dimethylurea), supporting a role of oxidative stress in the activation of SUMOylation. In addition, SUMOylation by SUMO-2/3, but not SUMO-1, was partially suppressed by pifithrin-alpha (a pharmacological inhibitor of p53), supporting a role of p53 in SUMOylation by SUMO-2/3. We further examined the role of SUMOylation during cisplatin treatment of RPTC by using ginkgolic acid (GA), a pharmacological inhibitor of SUMOylation. Pretreatment with GA suppressed SUMOylation and importantly, GA enhanced apoptosis during cisplatin incubation. Taken together, the results demonstrate the first evidence of SUMOylation in AKI and suggest that SUMOylation may play a cytoprotective role in kidney tubular cells.

Original languageEnglish (US)
Pages (from-to)482-489
Number of pages8
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1852
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Sumoylation
Acute Kidney Injury
Ubiquitin
Cisplatin
Kidney
Pharmacology
Acetylcysteine
Kidney Diseases
Post Translational Protein Processing

Keywords

  • Apoptosis
  • Cisplatin nephrotoxicity
  • P53
  • ROS
  • Renal ischemia-reperfusion
  • SUMOylation

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Cite this

SUMOylation occurs in acute kidney injury and plays a cytoprotective role. / Guo, Chunyuan; Wei, Qingqing; Su, Yunchao; Dong, Zheng.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, No. 3, 01.03.2015, p. 482-489.

Research output: Contribution to journalArticle

@article{0f7822f045734c52b031ecd9624dfd6b,
title = "SUMOylation occurs in acute kidney injury and plays a cytoprotective role",
abstract = "SUMOylation is a form of post-translational modification where small ubiquitin-like modifiers (SUMO) are covalently attached to target proteins to regulate their properties. SUMOylation has been demonstrated during cell stress and implicated in cellular stress response. However, it is largely unclear if SUMOylation contributes to the pathogenesis of kidney diseases, such as acute kidney injury (AKI). Here we have demonstrated a dynamic change of protein SUMOylation in ischemic and cisplatin nephrotoxic AKI in mice. In rat kidney proximal tubular cells (RPTC), cisplatin-induced SUMOylation was diminished by two antioxidants (N-acetylcysteine and dimethylurea), supporting a role of oxidative stress in the activation of SUMOylation. In addition, SUMOylation by SUMO-2/3, but not SUMO-1, was partially suppressed by pifithrin-alpha (a pharmacological inhibitor of p53), supporting a role of p53 in SUMOylation by SUMO-2/3. We further examined the role of SUMOylation during cisplatin treatment of RPTC by using ginkgolic acid (GA), a pharmacological inhibitor of SUMOylation. Pretreatment with GA suppressed SUMOylation and importantly, GA enhanced apoptosis during cisplatin incubation. Taken together, the results demonstrate the first evidence of SUMOylation in AKI and suggest that SUMOylation may play a cytoprotective role in kidney tubular cells.",
keywords = "Apoptosis, Cisplatin nephrotoxicity, P53, ROS, Renal ischemia-reperfusion, SUMOylation",
author = "Chunyuan Guo and Qingqing Wei and Yunchao Su and Zheng Dong",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.bbadis.2014.12.013",
language = "English (US)",
volume = "1852",
pages = "482--489",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - SUMOylation occurs in acute kidney injury and plays a cytoprotective role

AU - Guo, Chunyuan

AU - Wei, Qingqing

AU - Su, Yunchao

AU - Dong, Zheng

PY - 2015/3/1

Y1 - 2015/3/1

N2 - SUMOylation is a form of post-translational modification where small ubiquitin-like modifiers (SUMO) are covalently attached to target proteins to regulate their properties. SUMOylation has been demonstrated during cell stress and implicated in cellular stress response. However, it is largely unclear if SUMOylation contributes to the pathogenesis of kidney diseases, such as acute kidney injury (AKI). Here we have demonstrated a dynamic change of protein SUMOylation in ischemic and cisplatin nephrotoxic AKI in mice. In rat kidney proximal tubular cells (RPTC), cisplatin-induced SUMOylation was diminished by two antioxidants (N-acetylcysteine and dimethylurea), supporting a role of oxidative stress in the activation of SUMOylation. In addition, SUMOylation by SUMO-2/3, but not SUMO-1, was partially suppressed by pifithrin-alpha (a pharmacological inhibitor of p53), supporting a role of p53 in SUMOylation by SUMO-2/3. We further examined the role of SUMOylation during cisplatin treatment of RPTC by using ginkgolic acid (GA), a pharmacological inhibitor of SUMOylation. Pretreatment with GA suppressed SUMOylation and importantly, GA enhanced apoptosis during cisplatin incubation. Taken together, the results demonstrate the first evidence of SUMOylation in AKI and suggest that SUMOylation may play a cytoprotective role in kidney tubular cells.

AB - SUMOylation is a form of post-translational modification where small ubiquitin-like modifiers (SUMO) are covalently attached to target proteins to regulate their properties. SUMOylation has been demonstrated during cell stress and implicated in cellular stress response. However, it is largely unclear if SUMOylation contributes to the pathogenesis of kidney diseases, such as acute kidney injury (AKI). Here we have demonstrated a dynamic change of protein SUMOylation in ischemic and cisplatin nephrotoxic AKI in mice. In rat kidney proximal tubular cells (RPTC), cisplatin-induced SUMOylation was diminished by two antioxidants (N-acetylcysteine and dimethylurea), supporting a role of oxidative stress in the activation of SUMOylation. In addition, SUMOylation by SUMO-2/3, but not SUMO-1, was partially suppressed by pifithrin-alpha (a pharmacological inhibitor of p53), supporting a role of p53 in SUMOylation by SUMO-2/3. We further examined the role of SUMOylation during cisplatin treatment of RPTC by using ginkgolic acid (GA), a pharmacological inhibitor of SUMOylation. Pretreatment with GA suppressed SUMOylation and importantly, GA enhanced apoptosis during cisplatin incubation. Taken together, the results demonstrate the first evidence of SUMOylation in AKI and suggest that SUMOylation may play a cytoprotective role in kidney tubular cells.

KW - Apoptosis

KW - Cisplatin nephrotoxicity

KW - P53

KW - ROS

KW - Renal ischemia-reperfusion

KW - SUMOylation

UR - http://www.scopus.com/inward/record.url?scp=84920093315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920093315&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2014.12.013

DO - 10.1016/j.bbadis.2014.12.013

M3 - Article

C2 - 25533125

AN - SCOPUS:84920093315

VL - 1852

SP - 482

EP - 489

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 3

ER -